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Student Activity
Background
Human immunodeficiency virus (HIV) particles, a.k.a.
virions, can exist in the bloodstream of an infected
individual. However, HIV replication or production of
more HIV virions occurs within cells of the lymph nodes
of an infected individual. HIV is capable of infecting
multiple human cell types, but for simplicity’s sake, we will
focus on HIV infection of CD4-positive immune cells, a.k.a.
T helper cells.
The HIV envelope protein (Env) is essential for binding
to a human lymphocyte or T cell. Env is composed of two
subunits, a transmembrane protein called gp41 and a
surface protein gp120, which are attached to one another
noncovalently (Fig. 1). This dimer associates with two
other dimers forming the trimer that binds to CD4 receptors
on the surface of the lymphocyte. CD4 receptors usually act
as adhesion molecules to bind to other immune cells such
as antigen-presenting cells, but HIV takes advantage of this
receptor and uses it to bind to the T cell. A third type of
receptor involved in this interaction, called a coreceptor, is
also required for HIV infection. This coreceptor is located
on the T cell. HIV also needs either the coreceptor CCR5 or
the coreceptor CXCR4 to enter the cell. Different types of T
cells will express CCR5 or CXCR4 on their cell surface.
Regions within the gp120 subunit of the envelope protein
interact with both CD4 and the coreceptor, causing
conformational changes in the envelope protein. This
initiates the fusion of the HIV and the T cell lipid
membranes, ultimately leading to the insertion of HIV's
RNA genome into the host cell, subsequent copying of the
RNA genome into double-stranded DNA, integration into
the host's genome, and production of new virus particles.
Scientists have found that the fitness of an HIV virion is
directly correlated with how fast it can infect a cell, so they
are very interested in studying the evolution of gp120 in
particular. The gp120 domain is important because it is a
target for our immune system. The gp120 protein is
composed of five hypervariable regions separated by
constant regions.
The V1/V2 region is involved in modulating the
interaction of the envelope receptor with CD4. Both the
V1 region and V2 region consist of approximately 40
amino acids each. The V3 region is important for
modulating interactions with the coreceptors CCR5 and
CXCR4. Little is known about the function of V4/V5, but
the region has been shown to contain epitopes for
neutralizing antibodies.
The simian immunodeficiency virus (SIV) is very similar
to HIV. In fact, HIV evolved from SIV. SIV is endogenous
to nonhuman primate populations (chimpanzees, macaques,
etc.). The Rhesus macaque serves as a model organism to
study SIV infection and pathogenesis. There are many
similarities between how SIV infects macaques and how
HIV infects humans, although with some differences. Thus,
scientists can learn much from experimenting with the
SIV–macaque model to further determine molecular events
during HIV infection of humans.
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Preactivity Questions
1. If a polypeptide contains 40 amino acids, how many
nucleotides does this represent?
2. Briefly describe how HIV evolution occurs.
3. What are the specific functions of the V1/V2 region of
the envelope protein? What about the V3 region?
Envelope Sequence Analysis Activity
The Experiment
Ten Rhesus macaques were infected with the SIV via
intravenous injection and ten macaques were infected via a
mucosal route of infection, mimicking sexual transmission.
Plasma samples were taken at time points 2, 4, 6, 8, 12, 24,
and 32 weeks after infection. Virus RNA was isolated from
the samples, RT-PCR was performed to specifically amplify
the V1/V2 region, and the products were visualized using
gel electrophoresis and sequenced.
Hypotheses
& Similar amino acid changes occur in the V1/V2 region
comparing macaques infected via the two routes of
infection, intravenous and mucosal.
& However, the route of infection, how the virus enters
the host, will affect the rate of V1/V2 evolution.
Your goal is to describe the changes that occur in the
V1/V2 hypervariable regions of the gp120 protein
during virus infection and determine if the data
supports or refutes the hypotheses above.
Data
A) Table 1 indicates the number of SIV V1/V2 variants
present in the sample at each time point after infection
from three macaques infected through the intravenous
route (IV) and three macaques infected through the
mucosal (M) route.
B) Amino acid sequences obtained from the samples are
provided in the file SIV_V1_V2 sequences.txt.
Each sequence is given a unique name. For example, the
sequence name JJW_IV_wk2_variant1 indicates the name
of the macaque subject (JJW) followed by the mode of
infection (IV, intravenous or M, mucosal), time point after
infection (week 2), and the variant found (clone 1).
Sequence Analysis
Quick guide for Biology Workbench
(http://workbench.sdsc.edu/)
1. Log into Biology Workbench, click the Session Tools
button, select New, give your session a name, click
Start New Session.
2. Upload sequences into the session. Batch uploading
as described below will upload all the sequences
from the one file provided and then separate each
sequence so you can choose specific ones to work
with later.
& Click the Protein Tools button since the data is
amino acid sequences.
& Click Add button. Browse your desktop to upload
the sequence file SIV_V1_V2 sequences.txt into
your session. Click the Upload File button, then
click the Save button at the bottom of your
sequence text boxes.
Fig. 1 Envelope protein linear schematic. Constant regions are
represented by C1, C2... and variable regions are represented by V1,
V2.... SU surface domain, TM transmembrane domain, which anchors
the protein into a lipid membrane. Other domains within gp41 are not
indicated on this diagram
Table 1 The number of SIV V1/V2 variants present in the sample at each time point after infection




2 weeks 4 weeks 6 weeks 8 weeks 12 weeks 24 weeks 32 weeks
JJW IV 2 2 2 2 8 7 6
PDW IV 1 3 3 6 9 7 2
TDB IV 3 3 3 4 11 9 8
AU86 M 2 2 2 2 2 4 7
AV87 M 4 4 4 4 4 7 8
AV95 M 1 1 1 1 1 2 4
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3. Now each sequence is uploaded separately into your
session and you are ready to do more advanced
manipulations.
4. Alignments:
& Select the sequences you want to align by clicking
the box next to the sequence name.
& Select appropriate alignment algorithm (CLUS-
TALW–Multiple Sequence Alignment will suffice
for this exercise).
& The next window will allow you to change various
parameters. No need to change anything for this
analysis so click the Submit button. Your sequen-
ces will be aligned.
& You can save screen shots of your alignments
(Print Screen button on the PC) and paste into a
blank document for further analysis or just high-
light the text and copy and paste into a document.
Make sure you include the reference sequence
named “ref_smh_4” in each of your alignments as
the wild type comparison sequence.
Analysis Questions
1. What are your observations and conclusions from the
data in Table 1? Does the data support or refute the
hypotheses proposed?
2. What are your observations and conclusions from the
sequence analysis? Does the data support or refute the
hypotheses proposed?
3. Propose reasons why there are similarities and differ-
ences in both the timing and the specific amino acid
changes that occur in HIV after infection in these two
groups of subjects.
4. How is natural selection and microevolution illustrated
in this experiment? In other words, identify the genetic
basis for evolutionary change, possible selective pres-
sures, and the resulting adaptation illustrated in the
experiment. What happens to the HIV mutants that are
able to escape detection by the immune system?
5. Would the envelope protein serve as an effective
component of an anti-HIV vaccine? Why and why not?
Instructor Guide
Introduction
The human immunodeficiency virus (HIV) has become a
major health epidemic and currently, there are nearly 40
million people worldwide affected by HIV/AIDS
(UNAIDS/WHO, http://www.unaids.org). Basic scientific
research has uncovered many facets to the biology of the
virus, including how HIV evolves at a molecular level. This
module focuses on the envelope protein, a receptor on the
surface of the virus. The activity will provide students a
hands-on experience working with actual scientific data to
elucidate the molecular evolution of the virus during the
infection of a host.
Learning Objectives
& Describe the process of microevolution of the envelope
protein.
& Propose possible selective pressures involved in virus
evolution.
& Analyze molecular evidence for evolution of the SIV
envelope protein.
& Propose ideas of why the envelope protein may be an
effective or ineffective component of an anti-HIV
vaccine.
Implementation
& This lesson is primarily targeted to undergraduate
students who have previous knowledge of basic cell
biology and genetics.
& Students should have basic knowledge of the HIV life
cycle and the immune system. Students and instructors
should visit the Centers for Disease Control and
Prevention website (http://www.cdc.gov/hiv/) and con-
sult other resources for background information about
HIV infection.
& Students can answer the preactivity questions using
reliable Internet resources and cite the references they
used. Answers can be shared at the start of the sequence
analysis activity (5 min).
& A computer with Internet connectivity is needed for
each pair of students to perform the sequence analysis
activity outlined below. As an alternative, instructors
can provide students the sequence alignment in the
“Answer Key” below and then ask students to analyze
this data to answer the questions.
& Students will use actual amino acid sequences from SIV
to determine specific changes that occur during the
course of infection as evidence of microevolution.
& Any program that has sequence alignment tools and
uses sequences in FASTA format will be sufficient. One
suggested resource is Biology Workbench (http://work
bench.sdsc.edu/), a free, student friendly bioinformatics
resource.
& Once students are logged in, they will need to upload
the protein sequence data file “SIV_V1_V2 sequences.
txt” provided in this module. The sequences can be
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uploaded in batch. Students will use the CLUSTALW–
Multiple Sequence Alignment function to compare
sequences.
& A reference/wild-type SIV sequence is provided in the
data named “ref_smh_4”
& Sequence alignment and data collection can be per-
formed in a 50-min period followed by a 30-min
debriefing session to discuss the analysis questions.
Answer Key
Preactivity Questions
1. If a polypeptide sequence has 40 amino acids, how
many nucleotides does this represent?
Each amino acid is encoded by 1 codon, 1 codon is
composed of 3 nucleotides, then 40 amino acids×3
nucleotides=120 nucleotides.
2. Briefly describe the steps involved in how HIV
evolution occurs.
Random mutations occur in the RNA genome when
reverse transcriptase converts the RNA into DNA;
these mutations are not corrected and are passed on in
subsequent replication cycles. Selective pressures will
change the frequency of certain variants in a popula-
tion. Those virions adapted to a specific environment
are considered “fit” and will survive.
3. What are the specific functions of the V1/V2 region of
the envelope protein? What about the V3 region?
V1/V2 modulates interactions with CD4 and it is an
antigenic region containing epitopes where antibodies
bind. The V3 region modulates interactions with
CCR5 and CXCR4 coreceptors.
Analysis Questions
1. What are your observations and conclusions from the
data in Table 1? Does the data support or refute the
hypotheses proposed?
The table shows that in general, for the macaque
subjects infected via IV, the number of variants in each
subject quickly increases between weeks 8 and 12
after infection. For macaque subjects infected via the
mucosal route, the number of variants increases much
later, at 24 weeks. Thus, this data supports the
hypothesis that the route of infection does affect the
rate of SIV evolution.
2. What are your observations and conclusions from the
sequence analysis? Does the data support or refute the
hypotheses proposed?
Students should do multiple comparisons between the
early time point and later time point within one subject
(i.e., JJW_IV_wk2 and JJW_IV_wk12), and between
the two subjects. Many more changes in the V1 region
compared with the V2 region are evident. In JJW,
these changes occur earlier compared to macaque
AV95. There are no consistent sequence changes
between JJW and AV95, although there are hot spots
where amino acid changes occur more frequently in
both subjects, especially in the V1 region (see green
highlighted amino acids in the alignment below).
3. Propose reasons why there are similarities and differences
in both the timing and the specific amino acid changes
that occur in HIV after infection in these two subjects.
Students should note that the time when sequence
changes are evident occurs much earlier in the IV-
infected macaques (12 weeks) compared to the
mucosal-infected macaques. Possible reasons could
be that there are different selective pressures influenc-
ing the timing of when the sequence changes occur in
the two groups. Since the two groups were inoculated
with the virus via different routes of transmission, the
microenvironment of the initial establishment of
infection could play a role in how and when the virus
evolves. These microenvironments can also include
different initial immune responses, for example,
different antibody subtypes predominant in different
parts of the host (IgA antibodies are more common
near mucosal surfaces).
4. How is natural selection and microevolution illustrated
in this experiment? In other words, identify the genetic
basis for evolutionary change, possible selective pres-
sures, and the resulting adaptation illustrated in the
experiment. What happens to the HIV mutants that are
able to escape detection by the immune system?
The genetic basis for evolutionary change is the
mutations that arise during the virus life cycle when its
genome is being replicated. Selective pressures may
include host Tcell and B cell responses, specific subtype
antibody responses, the microenvironment present when
the virus enters the host, and the general state of the
immune system during infection. The resulting adapta-
tion is the development of variants which are not
recognized by the immune system. The variants have a
higher fitness compared to wild-type virus and, there-
fore, will go on to replicate and persist in the host.
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Sample Alignment
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5. Would the envelope protein serve as an effective
component of an anti-HIV vaccine? Why and why not?
Researchers have logically chosen the envelope protein
as a vaccine candidate since it is an outer surface,
membrane protein easily accessible to the host's
immune system. It also has constant regions which
are generally not altered over the course of infection.
However, if this protein evolves over time, specifical-
ly in the hypervariable regions like V1/V2, it is a moving
target for the immune system and, thus, does not make
for an effective vaccine. For example, if the host
generates antibodies which specifically recognize an
epitope within the V1/V2 region at week 2, by week 12,
this same region could have evolved to escape antibody
detection and the antibodies generated at week 2 will no
longer recognize the epitope at week 12. Therefore,
vaccines based solely on the envelope protein have not
been shown to be 100% effective. The constant regions
of the protein which do not evolve would be more
effective antigenic components, while the hypervariable
regions would not. Changes in glycosylation sites of
gp120 can also modulate the antigenicity of HIV and,
thus, can prevent antibodies from binding to certain
regions of the protein allowing virus variants to go
undetected by the immune system.
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